Dose adjustment in renal impairment: response from Martindale: the Complete Drug Reference.
作者信息
Sweetman Sean C
出版信息
BMJ. 2005 Jul 30;331(7511):292-3. doi: 10.1136/bmj.331.7511.292-a.
Abstract
摘要
相似文献
1
Dose adjustment in renal impairment: response from Martindale: the Complete Drug Reference.
BMJ. 2005 Jul 30;331(7511):292-3. doi: 10.1136/bmj.331.7511.292-a.
2
Systematic comparison of four sources of drug information regarding adjustment of dose for renal function.
BMJ. 2005 Jul 30;331(7511):263. doi: 10.1136/bmj.38476.471088.3A. Epub 2005 May 19.
3
Dose adjustment in renal impairment: response from Drug Prescribing in Renal Failure.
BMJ. 2005 Jul 30;331(7511):293-4. doi: 10.1136/bmj.331.7511.293-a.
4
Dose adjustment in renal impairment: response from AHFS Drug Information.
BMJ. 2005 Jul 30;331(7511):293. doi: 10.1136/bmj.331.7511.293.
5
Dose adjustment in renal impairment: response from the British National Formulary.
BMJ. 2005 Jul 30;331(7511):292. doi: 10.1136/bmj.331.7511.292.
6
Drug administration.
Nurs Mirror Midwives J. 1975 Aug 28;141(9):56-9.
7
A set of simple aids to drug dosage adjustment in renal insufficiency.
Int J Clin Pharmacol Ther Toxicol. 1990 Jan;28(1):27-32.
8
Continuing the use of the Cockcroft-Gault equation for drug dosing in patients with impaired renal function.
Clin Pharmacol Ther. 2009 Nov;86(5):468-70. doi: 10.1038/clpt.2009.187.
9
Emerging evidence of the impact of kidney disease on drug metabolism and transport.
Clin Pharmacol Ther. 2008 Jun;83(6):898-903. doi: 10.1038/clpt.2008.59. Epub 2008 Apr 2.
10
Precision versus approximation: the trade off in assessing kidney function and drug dosing.
Pharmacotherapy. 2010 Aug;30(8):758-61. doi: 10.1592/phco.30.8.758.
引用本文的文献
1
Stability indicating green micellar liquid chromatographic method for simultaneous analysis of Metformin and dapagliflozin in their tablets.
BMC Chem. 2025 Jun 21;19(1):175. doi: 10.1186/s13065-025-01537-8.
2
Nanoencapsulation of amitriptyline enhances the potency of antidepressant-like effects and exhibits anxiolytic-like effects in Wistar rats.
PLoS One. 2025 Feb 28;20(2):e0316389. doi: 10.1371/journal.pone.0316389. eCollection 2025.
3
Mesalazine-Associated Agranulocytosis.
Am J Ther. 2024 Oct 16;32(2):e203-6. doi: 10.1097/MJT.0000000000001832.
4
Roles of Fatty Acid Chain Length and Enzyme-Oriented Drug Controlled Release from pH-Triggering Self-Assembled Fatty Acid Conjugated Quetiapine Nanosuspensions.
Int J Nanomedicine. 2023 Nov 30;18:7115-7131. doi: 10.2147/IJN.S440207. eCollection 2023.
5
Preparation and characterization of vaginal suppository of semisynthetic derivatives of ergot alkaloids cabergoline.
Saudi Pharm J. 2023 Dec;31(12):101849. doi: 10.1016/j.jsps.2023.101849. Epub 2023 Nov 4.
6
Clinical Data Repositories: Primary Sources of Drug-to-Drug Interaction Detection and Risk Assessment.
AMIA Annu Symp Proc. 2023 Apr 29;2022:625-633. eCollection 2022.
7
Isocratic ion pair chromatography for estimation of novel combined inhalation therapy that blocks coronavirus replication in chronic asthmatic patients.
Sci Rep. 2023 Jan 6;13(1):305. doi: 10.1038/s41598-023-27572-w.
8
Gas Chromatography-Mass Spectrometry Analysis of Anbarnesa Smoke and Its Antiviral Activity.
Adv Biomed Res. 2022 Oct 31;11:91. doi: 10.4103/abr.abr_92_21. eCollection 2022.
9
Response Surface Methodology for Optimization of Buspirone Hydrochloride-Loaded In Situ Gel for Pediatric Anxiety.
Gels. 2022 Jun 22;8(7):395. doi: 10.3390/gels8070395.
10
The efficacy of corticosteroid after facial nerve neurorrhaphy: a systematic review and meta-analysis of randomized controlled trial.
Braz J Otorhinolaryngol. 2023 Jan-Feb;89(1):79-89. doi: 10.1016/j.bjorl.2021.09.005. Epub 2021 Nov 2.
本文引用的文献
1
Systematic comparison of four sources of drug information regarding adjustment of dose for renal function.
BMJ. 2005 Jul 30;331(7511):263. doi: 10.1136/bmj.38476.471088.3A. Epub 2005 May 19.
Zotero 插件